Insider Transactions in Q3 2022 at Altimmune, Inc. (ALT)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 30
2022
|
Vipin K Garg President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,008
-1.27%
|
$36,096
$12.77 P/Share
|
|
Aug 31
2022
|
Vipin K Garg President and CEO |
SELL
Open market or private sale
|
Direct |
20,000
-7.79%
|
$400,000
$20.02 P/Share
|
|
Aug 30
2022
|
Vipin K Garg President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,007
-1.16%
|
$54,126
$18.94 P/Share
|
|
Aug 12
2022
|
John Gill Director |
SELL
Open market or private sale
|
Direct |
2,714
-49.48%
|
$40,710
$15.0 P/Share
|
|
Aug 12
2022
|
Vipin K Garg President and CEO |
SELL
Open market or private sale
|
Direct |
15,000
-5.46%
|
$225,000
$15.06 P/Share
|
|
Jul 31
2022
|
Matthew Scott Harris Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,076
+7.86%
|
$6,456
$6.86 P/Share
|
|
Jul 31
2022
|
M Scot Roberts Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
732
+7.49%
|
$4,392
$6.86 P/Share
|
|
Jul 31
2022
|
Richard I Eisenstadt Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,366
+50.0%
|
$8,196
$6.86 P/Share
|
|
Jul 30
2022
|
Vipin K Garg President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,007
-1.08%
|
$36,084
$12.01 P/Share
|
|
Jul 05
2022
|
M Scot Roberts Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,182
-55.08%
|
$122,184
$12.0 P/Share
|
|
Jul 05
2022
|
M Scot Roberts Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
787
+4.08%
|
$1,574
$2.95 P/Share
|
|
Jul 01
2022
|
M Scot Roberts Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
26,982
-60.39%
|
$323,784
$12.0 P/Share
|
|
Jul 01
2022
|
M Scot Roberts Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
26,982
+24.78%
|
$53,964
$2.78 P/Share
|